Fig. 6From: Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre studyKaplan–Meier analysis of 30-day mortality in patients with severe community-acquired pneumonia. Analysis was stratified by soluble urokinase-type plasminogen activator receptor (suPAR) (a) and syndecan-4 (b) levelsBack to article page